All News

The oral angiogenesis inhibitor pazopanib (Votrient) more than doubled progression-free survival versus placebo in a randomized, phase III trial of patients with advanced renal cell carcinoma.

The study adds to a growing body of literature now suggesting that ADT in combination with EBRT is not indicated for the low-risk patient.

Low-income prostate cancer patients are far more likely to undergo surgery for their disease if they are treated in a county hospital versus a private provider.

Medical practices around the country face continued challenges with managing a diverse work force that spans three generations.

Often neglected in the life insurance strategy is the estate tax consequence associated with the ownership and ultimate payout of the insurance policy's death benefit.

In children who show signs of readiness, toilet training is best initiated between the ages of 27 and 32 months.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV erectile dysfunction trials that are currently recruiting participants. This list is current as of March 17, 2010.

Recently published data analyses provide further evidence in support of assessing sexual health as a simple, low-cost strategy to augment traditional screening for cardiovascular disease (CVD) risk in men.

Results of a retrospective analysis, including data from a multi-institutional cohort of more than 1,200 men, suggest that obesity and race may be important modifiers in determining the association between diabetes and prostate cancer aggressiveness.

Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease.

Private payer rules differ from Medicare rules. From payment for procedures to globals, bundling, coverage, and modifier usage, private payers are not required to use Medicare rules.

Research characterizing the features of putative prostate cancer stem cells and their susceptibility to telomerase inhibition has important implications for understanding the biology of prostate cancer and for suggesting a new approach to treatment of advanced disease.

The FDA has approved the first generic version of tamsulosin hydrochloride capsules, 0.4 mg, to treat BPH.

A 2-year assessment of patients implanted with the urethral bulking agent Macroplastique (Uroplasty, Minnetonka, MN) for the treatment of female stress urinary incontinence showed that 84% of patients maintained significant improvement from their 12-month assessment.

Sipuleucel-T (Provenge) extends overall survival in men with metastatic, castrate-resistant prostate cancer, investigators in Dendreon Corp.?s phase III IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study recently announced at the 2010 Genitourinary Cancers Symposium in San Francisco.

Results from a phase III trial have shown that cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel (Taxotere)-based chemotherapy.

Men should discuss the uncertainties, risks, and potential benefits of screening for prostate cancer before deciding whether to be tested, according to newly updated prostate cancer screening guidelines from the American Cancer Society.

The Urgent PC System (Uroplasty, Inc., Minnetonka, MN) appears to improve urinary symptoms associated with overactive bladder, according to results of a recent multicenter trial.

The Calypso System (Calypso Medical Technologies, Inc., Seattle) offers a significant reduction in rectal and urinary treatment-related side effects during high-dose external beam radiation for prostate cancer, recent study findings show.

Obesity nearly doubles the risk of developing kidney stones, although the degree of obesity does not appear to increase or decrease the risk, according to a recent study from Johns Hopkins University, Baltimore.

Open radical prostatectomy and laparoscopic radical prostatectomy appear to offer comparable rates of success, according to a recent study from Memorial Sloan-Kettering Cancer Center, New York.

Diagnosing UTIs in teens can be tricky because symptoms of UTIs and STIs overlap. Antibiotics are standard treatment, though resistance is increasing.

Having too much available credit can hurt your credit score. A creditor can look at your available credit and have a concern that you'll run all of your cards to the maximum and declare bankruptcy.

While doctors in private practice explore cost-savings options such as sharing space with other physicians or peddling simple cosmetic procedures, more practices are streamlining their billing and collection programs.

Physicians are evaluating what the stock market nosedive has done to their portfolios and plans. Physicians who are at or near retirement have been forced to reconsider whether to retire, keep working, or go back to work if they are already retired.

As the recession lingers and more people lose jobs and health insurance, the consequences for medical practices are likely to grow more severe.

Although it's not the kind of gains you can take to the bank, one physician said he has found value in giving free annual exams to established patients who have recently lost their insurance.

A recent study demonstrated that long-term, low-dose trimethoprim-sulfamethoxazole (TMP-SMX) was associated with a modest decrease in urinary tract infections (UTIs) in children who had had at least 1 such symptomatic infection in the past.